Treat-to-target in systemic lupus erythematosus: Recommendations from an international task force

Ronald F. Van Vollenhoven, Marta Mosca, George Bertsias, David Isenberg, Annegret Kuhn, Kirsten Lerstrøm, Martin Aringer, Hendrika Bootsma, Dimitrios Boumpas, Ian N. Bruce, Ricard Cervera, Ann Clarke, Nathalie Costedoat-Chalumeau, L. Czirják, Ronald Derksen, Thomas Dörner, Caroline Gordon, Winfried Graninger, Frédéric Houssiau, Murat InancSøren Jacobsen, David Jayne, Anna Jedryka-Goral, Adrian Levitsky, Roger Levy, Xavier Mariette, Eric Morand, Sandra Navarra, Irmgard Neumann, Anisur Rahman, Jozef Rovenský, Josef Smolen, Carlos Vasconcelos, Alexandre Voskuyl, Anne Voss, Helena Zakharova, Asad Zoma, Matthias Schneider

Research output: Contribution to journalArticle

225 Citations (Scopus)

Abstract

The principle of treating-to-target has been successfully applied to many diseases outside rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic targets and pursuing these systematically has led to improved care for patients with these diseases and useful guidance for healthcare providers and administrators. Thus, an initiative to evaluate possible therapeutic targets and develop treatto- target guidance was believed to be highly appropriate in the management of systemic lupus erythematosus (SLE) patients as well. Specialists in rheumatology, nephrology, dermatology, internal medicine and clinical immunology, and a patient representative, contributed to this initiative. The majority convened on three occasions in 2012-2013. Twelve topics of critical importance were identified and a systematic literature review was performed. The results were condensed and reformulated as recommendations, discussed, modified and voted upon. The finalised bullet points were analysed for degree of agreement among the task force. The Oxford Centre level of evidence (LoE, corresponding to the research questions) and grade of recommendation (GoR) were determined for each recommendation. The 12 systematic literature searches and their summaries led to 11 recommendations. Prominent features of these recommendations are targeting remission, preventing damage and improving quality of life. LoE and GoR of the recommendations were variable but agreement was >0.9 in each case. An extensive research agenda was identified, and four overarching principles were also agreed upon. Treat-to-target-in-SLE (T2T/SLE) recommendations were developed by a large task force of multispecialty experts and a patient representative. It is anticipated that 'treating-to-target' can and will be applicable to the care of patients with SLE.

Original languageEnglish
Pages (from-to)958-967
Number of pages10
JournalAnnals of the Rheumatic Diseases
Volume73
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Advisory Committees
Systemic Lupus Erythematosus
Dermatology
Immunology
Patient Advocacy
Rheumatology
Patient Care
Nephrology
Internal Medicine
Allergy and Immunology
Administrative Personnel
Research
Health Personnel
Rheumatoid Arthritis
Quality of Life
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Van Vollenhoven, R. F., Mosca, M., Bertsias, G., Isenberg, D., Kuhn, A., Lerstrøm, K., ... Schneider, M. (2014). Treat-to-target in systemic lupus erythematosus: Recommendations from an international task force. Annals of the Rheumatic Diseases, 73(6), 958-967. https://doi.org/10.1136/annrheumdis-2013-205139

Treat-to-target in systemic lupus erythematosus : Recommendations from an international task force. / Van Vollenhoven, Ronald F.; Mosca, Marta; Bertsias, George; Isenberg, David; Kuhn, Annegret; Lerstrøm, Kirsten; Aringer, Martin; Bootsma, Hendrika; Boumpas, Dimitrios; Bruce, Ian N.; Cervera, Ricard; Clarke, Ann; Costedoat-Chalumeau, Nathalie; Czirják, L.; Derksen, Ronald; Dörner, Thomas; Gordon, Caroline; Graninger, Winfried; Houssiau, Frédéric; Inanc, Murat; Jacobsen, Søren; Jayne, David; Jedryka-Goral, Anna; Levitsky, Adrian; Levy, Roger; Mariette, Xavier; Morand, Eric; Navarra, Sandra; Neumann, Irmgard; Rahman, Anisur; Rovenský, Jozef; Smolen, Josef; Vasconcelos, Carlos; Voskuyl, Alexandre; Voss, Anne; Zakharova, Helena; Zoma, Asad; Schneider, Matthias.

In: Annals of the Rheumatic Diseases, Vol. 73, No. 6, 2014, p. 958-967.

Research output: Contribution to journalArticle

Van Vollenhoven, RF, Mosca, M, Bertsias, G, Isenberg, D, Kuhn, A, Lerstrøm, K, Aringer, M, Bootsma, H, Boumpas, D, Bruce, IN, Cervera, R, Clarke, A, Costedoat-Chalumeau, N, Czirják, L, Derksen, R, Dörner, T, Gordon, C, Graninger, W, Houssiau, F, Inanc, M, Jacobsen, S, Jayne, D, Jedryka-Goral, A, Levitsky, A, Levy, R, Mariette, X, Morand, E, Navarra, S, Neumann, I, Rahman, A, Rovenský, J, Smolen, J, Vasconcelos, C, Voskuyl, A, Voss, A, Zakharova, H, Zoma, A & Schneider, M 2014, 'Treat-to-target in systemic lupus erythematosus: Recommendations from an international task force', Annals of the Rheumatic Diseases, vol. 73, no. 6, pp. 958-967. https://doi.org/10.1136/annrheumdis-2013-205139
Van Vollenhoven, Ronald F. ; Mosca, Marta ; Bertsias, George ; Isenberg, David ; Kuhn, Annegret ; Lerstrøm, Kirsten ; Aringer, Martin ; Bootsma, Hendrika ; Boumpas, Dimitrios ; Bruce, Ian N. ; Cervera, Ricard ; Clarke, Ann ; Costedoat-Chalumeau, Nathalie ; Czirják, L. ; Derksen, Ronald ; Dörner, Thomas ; Gordon, Caroline ; Graninger, Winfried ; Houssiau, Frédéric ; Inanc, Murat ; Jacobsen, Søren ; Jayne, David ; Jedryka-Goral, Anna ; Levitsky, Adrian ; Levy, Roger ; Mariette, Xavier ; Morand, Eric ; Navarra, Sandra ; Neumann, Irmgard ; Rahman, Anisur ; Rovenský, Jozef ; Smolen, Josef ; Vasconcelos, Carlos ; Voskuyl, Alexandre ; Voss, Anne ; Zakharova, Helena ; Zoma, Asad ; Schneider, Matthias. / Treat-to-target in systemic lupus erythematosus : Recommendations from an international task force. In: Annals of the Rheumatic Diseases. 2014 ; Vol. 73, No. 6. pp. 958-967.
@article{110a13f201ca47ee9a4b730b3119a1ac,
title = "Treat-to-target in systemic lupus erythematosus: Recommendations from an international task force",
abstract = "The principle of treating-to-target has been successfully applied to many diseases outside rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic targets and pursuing these systematically has led to improved care for patients with these diseases and useful guidance for healthcare providers and administrators. Thus, an initiative to evaluate possible therapeutic targets and develop treatto- target guidance was believed to be highly appropriate in the management of systemic lupus erythematosus (SLE) patients as well. Specialists in rheumatology, nephrology, dermatology, internal medicine and clinical immunology, and a patient representative, contributed to this initiative. The majority convened on three occasions in 2012-2013. Twelve topics of critical importance were identified and a systematic literature review was performed. The results were condensed and reformulated as recommendations, discussed, modified and voted upon. The finalised bullet points were analysed for degree of agreement among the task force. The Oxford Centre level of evidence (LoE, corresponding to the research questions) and grade of recommendation (GoR) were determined for each recommendation. The 12 systematic literature searches and their summaries led to 11 recommendations. Prominent features of these recommendations are targeting remission, preventing damage and improving quality of life. LoE and GoR of the recommendations were variable but agreement was >0.9 in each case. An extensive research agenda was identified, and four overarching principles were also agreed upon. Treat-to-target-in-SLE (T2T/SLE) recommendations were developed by a large task force of multispecialty experts and a patient representative. It is anticipated that 'treating-to-target' can and will be applicable to the care of patients with SLE.",
author = "{Van Vollenhoven}, {Ronald F.} and Marta Mosca and George Bertsias and David Isenberg and Annegret Kuhn and Kirsten Lerstr{\o}m and Martin Aringer and Hendrika Bootsma and Dimitrios Boumpas and Bruce, {Ian N.} and Ricard Cervera and Ann Clarke and Nathalie Costedoat-Chalumeau and L. Czirj{\'a}k and Ronald Derksen and Thomas D{\"o}rner and Caroline Gordon and Winfried Graninger and Fr{\'e}d{\'e}ric Houssiau and Murat Inanc and S{\o}ren Jacobsen and David Jayne and Anna Jedryka-Goral and Adrian Levitsky and Roger Levy and Xavier Mariette and Eric Morand and Sandra Navarra and Irmgard Neumann and Anisur Rahman and Jozef Rovensk{\'y} and Josef Smolen and Carlos Vasconcelos and Alexandre Voskuyl and Anne Voss and Helena Zakharova and Asad Zoma and Matthias Schneider",
year = "2014",
doi = "10.1136/annrheumdis-2013-205139",
language = "English",
volume = "73",
pages = "958--967",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Treat-to-target in systemic lupus erythematosus

T2 - Recommendations from an international task force

AU - Van Vollenhoven, Ronald F.

AU - Mosca, Marta

AU - Bertsias, George

AU - Isenberg, David

AU - Kuhn, Annegret

AU - Lerstrøm, Kirsten

AU - Aringer, Martin

AU - Bootsma, Hendrika

AU - Boumpas, Dimitrios

AU - Bruce, Ian N.

AU - Cervera, Ricard

AU - Clarke, Ann

AU - Costedoat-Chalumeau, Nathalie

AU - Czirják, L.

AU - Derksen, Ronald

AU - Dörner, Thomas

AU - Gordon, Caroline

AU - Graninger, Winfried

AU - Houssiau, Frédéric

AU - Inanc, Murat

AU - Jacobsen, Søren

AU - Jayne, David

AU - Jedryka-Goral, Anna

AU - Levitsky, Adrian

AU - Levy, Roger

AU - Mariette, Xavier

AU - Morand, Eric

AU - Navarra, Sandra

AU - Neumann, Irmgard

AU - Rahman, Anisur

AU - Rovenský, Jozef

AU - Smolen, Josef

AU - Vasconcelos, Carlos

AU - Voskuyl, Alexandre

AU - Voss, Anne

AU - Zakharova, Helena

AU - Zoma, Asad

AU - Schneider, Matthias

PY - 2014

Y1 - 2014

N2 - The principle of treating-to-target has been successfully applied to many diseases outside rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic targets and pursuing these systematically has led to improved care for patients with these diseases and useful guidance for healthcare providers and administrators. Thus, an initiative to evaluate possible therapeutic targets and develop treatto- target guidance was believed to be highly appropriate in the management of systemic lupus erythematosus (SLE) patients as well. Specialists in rheumatology, nephrology, dermatology, internal medicine and clinical immunology, and a patient representative, contributed to this initiative. The majority convened on three occasions in 2012-2013. Twelve topics of critical importance were identified and a systematic literature review was performed. The results were condensed and reformulated as recommendations, discussed, modified and voted upon. The finalised bullet points were analysed for degree of agreement among the task force. The Oxford Centre level of evidence (LoE, corresponding to the research questions) and grade of recommendation (GoR) were determined for each recommendation. The 12 systematic literature searches and their summaries led to 11 recommendations. Prominent features of these recommendations are targeting remission, preventing damage and improving quality of life. LoE and GoR of the recommendations were variable but agreement was >0.9 in each case. An extensive research agenda was identified, and four overarching principles were also agreed upon. Treat-to-target-in-SLE (T2T/SLE) recommendations were developed by a large task force of multispecialty experts and a patient representative. It is anticipated that 'treating-to-target' can and will be applicable to the care of patients with SLE.

AB - The principle of treating-to-target has been successfully applied to many diseases outside rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic targets and pursuing these systematically has led to improved care for patients with these diseases and useful guidance for healthcare providers and administrators. Thus, an initiative to evaluate possible therapeutic targets and develop treatto- target guidance was believed to be highly appropriate in the management of systemic lupus erythematosus (SLE) patients as well. Specialists in rheumatology, nephrology, dermatology, internal medicine and clinical immunology, and a patient representative, contributed to this initiative. The majority convened on three occasions in 2012-2013. Twelve topics of critical importance were identified and a systematic literature review was performed. The results were condensed and reformulated as recommendations, discussed, modified and voted upon. The finalised bullet points were analysed for degree of agreement among the task force. The Oxford Centre level of evidence (LoE, corresponding to the research questions) and grade of recommendation (GoR) were determined for each recommendation. The 12 systematic literature searches and their summaries led to 11 recommendations. Prominent features of these recommendations are targeting remission, preventing damage and improving quality of life. LoE and GoR of the recommendations were variable but agreement was >0.9 in each case. An extensive research agenda was identified, and four overarching principles were also agreed upon. Treat-to-target-in-SLE (T2T/SLE) recommendations were developed by a large task force of multispecialty experts and a patient representative. It is anticipated that 'treating-to-target' can and will be applicable to the care of patients with SLE.

UR - http://www.scopus.com/inward/record.url?scp=84899937611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899937611&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2013-205139

DO - 10.1136/annrheumdis-2013-205139

M3 - Article

C2 - 24739325

AN - SCOPUS:84899937611

VL - 73

SP - 958

EP - 967

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -